Racial Disparities in Stem Cell Matching

The hard part is not blood type, it is genetic matching, and mixed ancestry makes the search space much smaller. Stem cell transplants are matched using HLA markers, which are inherited, so patients are most likely to match donors with similar ancestry. Registry diversity is still uneven, and NMDP says improving ethnic diversity improves every patient’s odds of finding a life saving match. That is why banking a child’s own cord blood can matter most for families least well served by donor registries.

• This is a registry composition problem as much as a biology problem. NMDP says matching is tied to inherited tissue markers and similar ethnic background, while the Anja interview explains donor pools have historically been recruited from whiter, higher income areas, leaving fewer close matches for many patients of color.
  1 nmdp 2 sacra
• Mixed race patients can be especially hard to match because HLA patterns come from both sides of a family tree. A review of cord blood banking found some underrepresented groups in the U.S. had a 5 to 20 times lower chance of finding a perfect 6 of 6 cord blood match than white European recipients.
  2 sacra 4 sciencedirect
• Autologous cord blood changes the equation because no donor search is needed. Duke has run clinical studies of a child’s own cord blood in cerebral palsy, and Duke reported improved motor function in some children at adequate cell doses, which helps explain why families see private banking as future treatment optionality, not just storage.
  3 clinicaltrials 5 duke 6 duke

The market is moving toward products that reduce dependence on scarce perfect matches, through private banking, better public inventory diversity, and transplant methods that work with looser matching. Companies like Anja are effectively selling guaranteed access to a biologically compatible starting point, which becomes more valuable as stem cell therapies expand beyond blood cancers into neurological and regenerative use cases.